Clinical Trial Update: A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ELLIPTA and BREEZHALER dry powder inhalers in adults with asthma; focuses on errors, training time, and user preferences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Breezhaler
• ELLIPTA

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2023-05-15